PHYZ Holdings Inc.
TSE:9325.T
891 (JPY) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 27,530.365 | 23,664.762 | 18,045.79 | 12,951.26 | 10,638.39 | 8,448.023 | 7,428.333 | 5,215.635 | 3,492.842 | 2,191.226 |
| Cost of Revenue
| 25,168.36 | 21,454.733 | 16,576.455 | 11,629.454 | 9,758.148 | 7,804.267 | 6,700.637 | 4,645.755 | 3,146.412 | 2,001.383 |
| Gross Profit
| 2,362.005 | 2,210.029 | 1,469.335 | 1,321.806 | 880.242 | 643.756 | 727.696 | 569.88 | 346.43 | 189.843 |
| Gross Profit Ratio
| 0.086 | 0.093 | 0.081 | 0.102 | 0.083 | 0.076 | 0.098 | 0.109 | 0.099 | 0.087 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 196 | 214 | 167 | 126 | 83 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 846.13 | 784 | 672 | 560 | 384 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1,042.13 | 998 | 839 | 686 | 467 | 391 | 237.843 | 219.092 | 200.985 | 0 |
| Other Expenses
| -61.864 | 14.983 | -5.448 | -4.643 | 2.167 | 3.512 | -0.036 | -5.745 | 0.712 | 0.005 |
| Operating Expenses
| 1,042.13 | 1,067.068 | 893.752 | 726.102 | 530.974 | 456.588 | 258.094 | 224.308 | 233.086 | 154.239 |
| Operating Income
| 1,319.875 | 1,142.961 | 575.582 | 595.703 | 349.266 | 187.167 | 469.601 | 345.571 | 113.343 | 35.603 |
| Operating Income Ratio
| 0.048 | 0.048 | 0.032 | 0.046 | 0.033 | 0.022 | 0.063 | 0.066 | 0.032 | 0.016 |
| Total Other Income Expenses Net
| 45.51 | 63 | -5 | 4 | -17 | 22.569 | -0.69 | -16.399 | -8.99 | -7.736 |
| Income Before Tax
| 1,365.385 | 1,207.397 | 572.431 | 602.12 | 333.499 | 209.737 | 468.912 | 329.173 | 104.354 | 27.868 |
| Income Before Tax Ratio
| 0.05 | 0.051 | 0.032 | 0.046 | 0.031 | 0.025 | 0.063 | 0.063 | 0.03 | 0.013 |
| Income Tax Expense
| 451.512 | 391.412 | 190.98 | 222.865 | 148.332 | 76.363 | 167.448 | 128.221 | 56.842 | 22.833 |
| Net Income
| 853.983 | 807.632 | 368.458 | 376.499 | 183.891 | 133.374 | 301.463 | 200.951 | 47.512 | 5.034 |
| Net Income Ratio
| 0.031 | 0.034 | 0.02 | 0.029 | 0.017 | 0.016 | 0.041 | 0.039 | 0.014 | 0.002 |
| EPS
| 79.6 | 75.3 | 34.37 | 35.14 | 17.09 | 12.47 | 27.73 | 23.31 | 6.12 | 0.59 |
| EPS Diluted
| 79.47 | 75.16 | 34.29 | 35.04 | 17.03 | 12.28 | 27.73 | 21.36 | 6.12 | 0.52 |
| EBITDA
| 1,494.216 | 1,339.014 | 719.637 | 696.346 | 415.307 | 232.122 | 490.893 | 366.419 | 175.665 | 99.855 |
| EBITDA Ratio
| 0.054 | 0.057 | 0.04 | 0.054 | 0.039 | 0.027 | 0.066 | 0.07 | 0.05 | 0.046 |